NFKB1 and neoplasm: The transcription factor NF-κB promotes tumor resistance to chemotherapy and immunotherapy by inducing the expression of anti-apoptotic gene products related to B-cell lymphoma 2 (Bcl-2) and regulating/decreasing the expression of death receptors (DRs) [74].